DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thymoglobulin (Anti-Thymocyte Globulin (Rabbit)) - Current Clinical Trials


Thymoglobulin Related Clinical Trials

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma [Completed]

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation [Recruiting]

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation [Recruiting]

Thymoglobulin (ATG) Dose Finding Study [Terminated]

Low Dose Thymoglobin in Renal Transplant Patients [Completed]

Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome [Completed]

Thymoglobulin Induction in Kidney Transplant Recipients [Not yet recruiting]

Thymoglobulin in Cadaver Donor [Completed]

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) [Terminated]

Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation [Recruiting]

Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection [Completed]

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Active, not recruiting]

Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation [Completed]

Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin [Terminated]

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT [Completed]

Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients [Completed]

Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg) [Not yet recruiting]

A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection [Completed]

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment [Completed]

Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk [Completed]

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants [Completed]

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant [Completed]

Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant [Active, not recruiting]

Studies of Kidney Transplant Outcome [Active, not recruiting]

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies [Completed]

Comparison of ATG to Thymoglobuline in Renal Transplantation [Completed]

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia [Active, not recruiting]

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation [Completed]

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation [Completed]

Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol [Recruiting]

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. [Completed]

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) [Recruiting]

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria [Recruiting]

A Study of Thymoglobulin and Tacrolimus in Liver Transplant [Enrolling by invitation]

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation [Terminated]

Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection [Completed]

Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA [Recruiting]

Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Completed]

Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients [Withdrawn]

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists [Active, not recruiting]

Allogeneic Stem Cell Transplantation for Myelofibrosis [Active, not recruiting]

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients [Terminated]

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation [Completed]

A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin´┐Ż in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV) [Not yet recruiting]

Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline«, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia [Active, not recruiting]

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation [Completed]

Regimen Optimization Study [Not yet recruiting]

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant [Terminated]

De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction [Terminated]

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA) [Active, not recruiting]

Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia [Recruiting]

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients [Completed]

Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status [Recruiting]

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant [Active, not recruiting]

Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors [Recruiting]

Study of Antithymocyte Globulin for Treatment of New-onset T1DM [Terminated]

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin [Completed]

Effects of Thymoglobulin on Human B Cells [Recruiting]

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant [Completed]

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) [Not yet recruiting]

Safety and Efficacy of a Steroid-free, Calcineurin Inhibitor-free, Belatacept-based Immunosuppressive Regimen [Active, not recruiting]

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal [Completed]

Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia [Completed]

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch [Recruiting]

AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Withdrawn]

Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients [Completed]

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML [Active, not recruiting]

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS) [Completed]

Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants [Completed]

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies [Active, not recruiting]

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab [Completed]

Reversing Type 1 Diabetes After it is Established [Active, not recruiting]

Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Completed]

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) [Active, not recruiting]

Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia [Recruiting]

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor [Terminated]

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies [Recruiting]

Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies [Recruiting]

Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia [Recruiting]

A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation [Completed]

Belatacept in Kidney Transplantation of Moderately Sensitized Patients [Recruiting]

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Terminated]

A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients [Completed]

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation [Completed]

Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation [Withdrawn]

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients [Not yet recruiting]

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) [Completed]

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies [Completed]

Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation [Active, not recruiting]

Evaluate Effects and Safety of Pre-load Myfortic« in Transplant Patients [Completed]

Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex«) in Patients at High Risk of Carrying Blood Diseases [Recruiting]

Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy [Recruiting]

Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols [Completed]

Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis [Recruiting]

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) [Recruiting]

Fludarabine-IV Busulfan ┬▒ Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Recruiting]

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients [Terminated]

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies [Active, not recruiting]

rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation [Enrolling by invitation]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017